Zide and Irinotecan hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zide (hydrochlorothiazide) and Irinotecan hydrochloride (irinotecan hydrochloride). Common drug interactions include febrile neutropenia among females and neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Zide and Irinotecan hydrochloride. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Zide?

Zide has active ingredients of hydrochlorothiazide. It is often used in high blood pressure. eHealthMe is studying from 183,246 Zide users. Check the latest studies of Zide.

What is Irinotecan hydrochloride?

Irinotecan hydrochloride has active ingredients of irinotecan hydrochloride. It is often used in cancer. eHealthMe is studying from 7,166 Irinotecan hydrochloride users. Check the latest studies of Irinotecan hydrochloride.



On Jul, 20, 2026

29 people who take Zide and Irinotecan hydrochloride together, and have interactions are studied.

Zide and Irinotecan hydrochloride drug interactions.

What are the common drug interactions of Zide and Irinotecan Hydrochloride, by gender? *:

female:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Fatigue (feeling of tiredness)
  3. Anaemia (lack of blood)
  4. Hypokalaemia (low potassium)
  5. Pneumonia
  6. Dehydration (dryness resulting from the removal of water)
  7. Hypotension (abnormally low blood pressure)
  8. Diarrhoea
  9. Death
  10. General physical health deterioration (weak health status)

male:

  1. Neutropenia (an abnormally low number of neutrophils)
  2. Blood creatinine increased
  3. Febrile neutropenia (fever with reduced white blood cells)
  4. Herpes zoster
  5. Mucosal inflammation (infection of mucous membrane)
  6. Perioral dermatitis (facial rash that causes bumps to develop around the mouth)
  7. Pruritus (severe itching of the skin)
  8. Pyrexia (fever)
  9. Rash
  10. Rectal haemorrhage (bleeding from anus)

What are the common drug interactions of Zide and Irinotecan Hydrochloride, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Pneumonia

50-59:

  1. Dehydration (dryness resulting from the removal of water)
  2. Fatigue (feeling of tiredness)
  3. Hypotension (abnormally low blood pressure)
  4. Diarrhoea
  5. Neutropenia (an abnormally low number of neutrophils)
  6. Acute hepatic failure
  7. Neutropenic sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection)

60+:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Anaemia (lack of blood)
  3. Enteritis (inflammation of the small intestine)
  4. General physical health deterioration (weak health status)
  5. Head injury
  6. Infection
  7. Loss of consciousness
  8. Nausea (feeling of having an urge to vomit)
  9. Neutropenia (an abnormally low number of neutrophils)
  10. Peripheral ischaemia (impaired circulation to an extremity)

What are the existing conditions these people have? *

  1. Colon Cancer: 8 people, 27.59%
  2. Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 5 people, 17.24%
  3. Weakness: 2 people, 6.90%
  4. Type 2 Diabetes: 2 people, 6.90%
  5. Pancreatic Carcinoma Metastatic (pancreatic cancer- metastatic): 2 people, 6.90%
  6. Oesophageal Cancer Metastatic (cancer of oesophagues spreads to other part): 2 people, 6.90%
  7. Metastatic Gastric Cancer (cancer types can spread to the stomach from other place): 2 people, 6.90%
  8. Glioblastoma Multiforme (most common and deadliest of malignant primary brain tumours in adults): 2 people, 6.90%
  9. Glioblastoma (most common and most aggressive malignant primary brain tumour in humans): 2 people, 6.90%
  10. Gastrointestinal Carcinoma (cancer of stomach or intestine): 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Zide and Irinotecan hydrochloride?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zide and Irinotecan hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Irinotecan hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Irinotecan hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on hydrochlorothiazide and irinotecan hydrochloride (the active ingredients of Zide and Irinotecan hydrochloride, respectively), and Zide and Irinotecan hydrochloride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: